Pseudomyxoma Peritonei — Trials

Pseudomyxoma Peritonei — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Aerospace Center Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07693452	Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms	recruiting	Phase 2	15	University of California, IrvineOTHER	1	Jul 13, 2026	clinicaltrials
NCT06800391	Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients(REVERSE)	recruiting	Phase 2	31	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Jan 30, 2025